A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections
暂无分享,去创建一个
D. V. van Schalkwyk | P. Chiodini | C. Drakeley | J. Cunningham | N. Sepúlveda | J. Parr | J. Juliano | S. Campino | C. Sutherland | J. Phelan | L. Grignard | D. Nolder | K. Moser | Donelly A. van Schalkwyk | A. Berhane | K. Beshir | R. Kaaya | Lynn Grignard | S. Mihreteab
[1] A. Adegnika,et al. Monitoring the threatened utility of malaria rapid diagnostic tests by novel high-throughput detection of Plasmodium falciparum hrp2 and hrp3 deletions: A cross-sectional, diagnostic accuracy study , 2019, EBioMedicine.
[2] Joana C. Silva,et al. A multiplex qPCR approach for detection of pfhrp2 and pfhrp3 gene deletions in multiple strain infections of Plasmodium falciparum , 2019, Scientific Reports.
[3] J. Cunningham,et al. pfhrp2 and pfhrp3 Gene Deletions That Affect Malaria Rapid Diagnostic Tests for Plasmodium falciparum: Analysis of Archived Blood Samples From 3 African Countries , 2019, The Journal of infectious diseases.
[4] Z. Mohamed,et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests , 2019, BMC Research Notes.
[5] W. Takken,et al. Molecular quantification of Plasmodium parasite density from the blood retained in used RDTs , 2019, Scientific Reports.
[6] L. Golassa,et al. Prevalence and epidemiological characteristics of asymptomatic malaria based on ultrasensitive diagnostics: A cross-sectional study. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] C. Sutherland,et al. Identifying Recrudescent Plasmodium falciparum in Treated Malaria Patients by Real-time PCR and High Resolution Melt Analysis of Genetic Diversity , 2018, Scientific Reports.
[8] T. Clark,et al. Global analysis of Plasmodium falciparum histidine-rich protein-2 (pfhrp2) and pfhrp3 gene deletions using whole-genome sequencing data and meta-analysis. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[9] S. Meshnick,et al. Streamlined, PCR-based testing for pfhrp2- and pfhrp3-negative Plasmodium falciparum , 2018, Malaria Journal.
[10] M. Gatton,et al. Major Threat to Malaria Control Programs by Plasmodium falciparum Lacking Histidine-Rich Protein 2, Eritrea , 2018, Emerging infectious diseases.
[11] J. Cunningham,et al. Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya , 2017, Scientific Reports.
[12] B. Sjögreen,et al. Methods to determine limit of detection and limit of quantification in quantitative real-time PCR (qPCR) , 2017, Biomolecular detection and quantification.
[13] M. Gatton,et al. Use of PfHRP2-only RDTs rapidly select for PfHRP2-negative parasites with serious implications for malaria case management and control , 2017 .
[14] M. Gatton,et al. Implications of Parasites Lacking Plasmodium falciparum Histidine-Rich Protein 2 on Malaria Morbidity and Control When Rapid Diagnostic Tests Are Used for Diagnosis , 2017, The Journal of infectious diseases.
[15] Mulugeta Russom,et al. Rapid diagnostic tests failing to detect Plasmodium falciparum infections in Eritrea: an investigation of reported false negative RDT results , 2017, Malaria Journal.
[16] Hannah C. Slater,et al. Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey , 2016, The Journal of infectious diseases.
[17] J. Barnwell,et al. Genetic Characterisation of Plasmodium falciparum Isolates with Deletion of the pfhrp2 and/or pfhrp3 Genes in Colombia: The Amazon Region, a Challenge for Malaria Diagnosis and Control , 2016, PloS one.
[18] Peter Chiodini,et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting , 2014, Malaria Journal.
[19] D. V. van Schalkwyk,et al. Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers , 2013, Malaria Journal.
[20] J. Baker,et al. Transcription and Expression of Plasmodium falciparum Histidine-Rich Proteins in Different Stages and Strains: Implications for Rapid Diagnostic Tests , 2011, PloS one.
[21] R. Hallett,et al. Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance , 2010, Malaria Journal.
[22] M. Perkins,et al. A Large Proportion of P. falciparum Isolates in the Amazon Region of Peru Lack pfhrp2 and pfhrp3: Implications for Malaria Rapid Diagnostic Tests , 2010, PloS one.
[23] V. Beneš,et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.
[24] J. Baker,et al. Effect of Sequence Variation in Plasmodium falciparum Histidine- Rich Protein 2 on Binding of Specific Monoclonal Antibodies: Implications for Rapid Diagnostic Tests for Malaria , 2006, Journal of Clinical Microbiology.
[25] F. Ramos. Report 2019 , 2019, Brazilian Business Review.
[26] V. Pande,et al. Genetic deletion of HRP2 and HRP3 in Indian Plasmodium falciparum population and false negative malaria rapid diagnostic test. , 2013, Acta tropica.
[27] Organización Mundial de la Salud. Malaria rapid diagnostic test performance: results of WHO product testing of malaria RDTs: round 1 (2008) , 2009 .